SAP30, an oncogenic driver of progression, poor survival, and drug resistance in neuroblastoma

• Main Authors: Philip Prathipati (Author), Anup S. Pathania (Author), Nagendra K. Chaturvedi (Author), Subash C. Gupta (Author), Siddappa N. Byrareddy (Author), Don W. Coulter (Author), Kishore B. Challagundla (Author)
• Format: Book
• Published: Elsevier, 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Neuroblastoma is the most devastating extracranial solid malignancy in children. Despite an intense treatment regimen, the prognosis for high-risk neuroblastoma patients remains poor, with less than 40% survival. So far, MYCN amplification status is considered the most prognostic factor but correspo...